Calidi Biotherapeutics is a biotechnology company focused on developing genetically engineered cell therapies for cancer and other complex diseases. Based in the United States, Calidi leverages its proprietary platform to deliver precise genetic medicines to disease sites, advancing pipelines in oncology and beyond. The company provides detailed scientific information, pipeline updates, and investor relations through its corporate website.
Calidi Biotherapeutics is listed with 1 API on the APIs.io network. Tagged areas include Company.
Calidi Biotherapeutics’ developer surface includes engineering blog and 6 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Horizontal (data, software, accessibility, platform) regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: calidi-biotherapeutics
name: Calidi Biotherapeutics
description: Calidi Biotherapeutics is a biotechnology company focused on developing genetically engineered cell therapies
for cancer and other complex diseases. Based in the United States, Calidi leverages its proprietary platform to deliver
precise genetic medicines to disease sites, advancing pipelines in oncology and beyond. The company provides detailed scientific
information, pipeline updates, and investor relations through its corporate website.
url: https://raw.githubusercontent.com/api-evangelist/calidi-biotherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-10-06 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-10-06'
modified: '2026-10-06'
tags:
- Company
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Hosts
url: hosts/calidi-biotherapeutics-hosts.yml
- type: Newsroom
url: https://ir.calidibio.com/news/default.aspx
- type: Leadership
url: https://www.calidibio.com/company/team/
- type: Blog
url: https://www.calidibio.com/blog/
- type: GitHubOrganization
url: https://github.com/forgeglobal
- type: DomainSecurity
url: security/calidi-biotherapeutics-domain-security.yml
- type: Website
url: https://www.calidibio.com/
apis:
- name: Calidi Biotherapeutics API
description: API documentation not publicly available; no machine-readable contract found.
humanURL: https://www.calidibio.com/
baseURL: null
aid: calidi-biotherapeutics:calidi-biotherapeutics-api
x-coverage:
state: unreadable
reason: no-machine-readable-spec
detail: No public API documentation or machine‑readable spec was found on the company’s website or API host.
evidence:
- url: https://api.calidibio.com/openapi.json
status: 0
checked: '2026-10-06'
x-enrichment:
date: '2026-10-06'
status: enriched
artifacts_added: 4
pass: modular-v1
engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →